Sungene biotech Co., Ltd. concentrates on the development, production and sales of high-quality antibody reagents, its products mainly includes flow cytometry specific fluorescently labeled antibody reagents, immunohistochemistry pathology antibody reagents, immune disease diagnosis kits and labeling loading control antibody reagents. Meanwhile, we also provide personalized antibody and labeling service. At present, the company has gained SFDA medical equipment production license.

    With company's rapid development and broad domestic antibodies market, they bring us an opportunity: we get the favor of state-owned investment ChangLu Gitzo Credit Group in funding, it is successful in investment intention in December 2012, they decide to support fund for  Tianjin Sungene biotech Co., Ltd, and seek mutual development together in 2013.

    This investment brings new resources and business opportunities, and it will accelerate the company development, so it can help us to continue implementing aggressive business plans in the coming years, in order to meet the growing needs of the market and produce antibodies from our own nation enterprises.